Investment Stage

Focus Areas

About Investor

Michael Rosenblatt serves as a Senior Partner at Flagship Pioneering, focusing on investments in pharmaceuticals, biotech, health IT, and health & hospital services sectors. He typically invests at the seed and Series A stages with an investment range of $500K - $15.0M. Rosenblatt is the Chief Medical Officer at Flagship Pioneering, where he leads global clinical development and medical affairs. He previously served as Executive Vice President and Chief Medical Officer at Merck from 2009 to 2016 and has had a distinguished career with prior appointments as Dean of Tufts University School of Medicine; Robert H. Ebert Professor of Molecular Medicine and George R. Minot Professor of Medicine at Harvard Medical School; and Director of the Harvard-MIT Division of Health Sciences and Technology. He holds 19 patents and has authored over 180 peer-reviewed papers and commentaries.